Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Viewpoint Molecular Targeting
AddedFeb 15, 2024
UpdatedJun 18, 2026
Viewpoint Molecular Targeting

Viewpoint Molecular Targeting

US-based Viewpoint Molecular Targeting, LLC, founded in 2009, specializes in manufacturing semiconductors.

HQ
Coralville, IA, US
Founded
2008
Overview
Compare
Fundraising
Employees

Viewpoint Molecular Targeting, LLC was founded in 2009.

The company's line of business includes the manufacturing of semiconductors and related solid-state devices.

Viewpoint Molecular Targeting - Similar Companies

Molecular Detection logo

Molecular Detection

Nanonexus logo

Nanonexus

Quantum Semiconductor logo

Quantum Semiconductor

quantumsemi.com

RF Nano logo

RF Nano

Solid Cell logo

Solid Cell

Vital View Technologies logo

Vital View Technologies

vitalviewtech.com

Integral Molecular logo

Integral Molecular

Boston Microtechnology logo

Boston Microtechnology

R2 Semiconductor logo

R2 Semiconductor

r2semi.com

Invenio Imaging logo

Invenio Imaging

US Nano logo

US Nano

usnanollc.com

Molecular Loop logo

Molecular Loop

ABT Molecular Imaging logo

ABT Molecular Imaging

Vascular Designs logo

Vascular Designs

Movellus logo

Movellus

movellus.com

Viewpoint Molecular Targeting - Quick Facts

Who are Viewpoint Molecular Targeting's competitors?

Companies similar to Viewpoint Molecular Targeting include Molecular Detection, Nanonexus, Quantum Semiconductor and RF Nano.

When was Viewpoint Molecular Targeting founded?

Viewpoint Molecular Targeting was founded in 2008.

Where is Viewpoint Molecular Targeting's headquarters located?

Viewpoint Molecular Targeting's headquarters is located in Coralville, IA, US.

When was Viewpoint Molecular Targeting's last funding round?

Viewpoint Molecular Targeting's most recent funding round was for $5M (USD) in January 2021.

How much has Viewpoint Molecular Targeting raised to-date?

As of Jan 21, 2021, Viewpoint Molecular Targeting has raised a total of $34.3M (USD).

How many employees does Viewpoint Molecular Targeting have?

Viewpoint Molecular Targeting has 14 employees as of Feb 5, 2024.

Viewpoint Molecular Targeting - Classification

Industry
  • Hardware
Ownership
  • Private
Geographic Exposure
  • United States
Revenue
  • Transactional
Customer
  • Enterprise
Main Product
  • Semiconductors
Tags
  • Manufacturing
NAICS
  • 334400Semiconductor and Other Electronic Component Manufacturing
  • 330000Manufacturing
  • 334000Computer and Electronic Product Manufacturing
  • 334410Semiconductor and Other Electronic Component Manufacturing
SIC
  • 3674Semiconductors And Related Devices
  • 3600Electronic And Other Electrical Equipment And Components, Except Computer
  • 3670Electronic Components And Accessories
Show 1 more industry code
SIC
  • 3900Miscellaneous Manufacturing Industries